Logo-BCC-Research.jpg
Metastatic Cancer Therapy Market to Approach $173B by 2022
16 nov. 2017 10h15 HE | BCC Research
WELLESLEY, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- The promise of alternative therapies and a better understanding of the genetic basis of cancers are driving the market for metastatic cancer...